Stellar Reports Positive Research Results from KLH Glycosylation Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Stellar Biotechnologies (SBOT) Gains 45% Following Positive Study Results
June 21, 2018 8:06 AM EDTStellar Biotechnologies (NASDAQ: SBOT) gains 45% in pre-open trade after the company announced the successful completion of a research study focused on the molecular composition of the company's KLH products. The quality analysis was completed as part of Stellar's initiatives to support later stage clinical trials of... More
